Cefazolin
Back to searchMolecule Structure
Scientific Name
Cefazolin
Description of the Drug
Cefazolin is a broad-spectrum cephalosporin antibiotic mainly used for the treatment of skin bacterial infections and other moderate to severe bacterial infections in the lung, bone, joint, stomach, blood, heart valve, and urinary tract.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01327
http://www.drugbank.ca/drugs/DB01327
Brand Name(s)
Not Available
Company Owner(s)
Glaxosmithkline, Hikma Farmaceutica Portugal Lda, Bedford Laboratories Div Ben Venue Laboratories Inc, Fresenius Kabi Usa Llc, Hospira Inc, Eli Lilly And Co, Aurobindo Pharma Ltd, Facta Farmaceutici Spa, Baxter Healthcare Corp, Samson Medical Technologies Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2841 | ||
| Human Metabolome Database | HMDB0015422 | ||
| DrugBank | DB01327 | ||
| PubChem: Thomson Pharma | 15008581 | 14833488 | |
| PubChem | 33255 | ||
| Mcule | MCULE-6391244021 | ||
| NMRShiftDB | 60027799 | ||
| LINCS | LSM-34744 | ||
| Nikkaji | J17.146H | ||
| BindingDB | 50370587 | ||
| EPA CompTox Dashboard | DTXSID2022753 | ||
| DrugCentral | 530 | ||
| Brenda | 153382 | 1488 | 154366 |
| ChemicalBook | CB3396249 | ||
| Guide to Pharmacology | 10935 | ||
| rxnorm | CEFAZOLIN | CEFAZOLIN SODIUM | |
| KEGG Ligand | C06880 | ||
| ChEBI | 474053 | ||
| ZINC | ZINC000003830405 |
